Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 8216723, 9 pages
https://doi.org/10.1155/2017/8216723
Research Article

Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients

1Kazan Federal University, Kremlyovskaya St, 18, Kazan 420000, Russia
2Nizhny Novgorod State Medical Academy, Minin and Pozharsky Square 10/1, Nizhny Novgorod 603005, Russia
3Pulmonology Research Institute, 11-Parkovaya 32, Moscow 105077, Russia
4I.M. Sechenov First Moscow State Medical University, Trubetskaya, 8- 2, Moscow, Russia
5Lobachevsky State University of Nizhny Novgorod, Gagarina Avenue 23, Nizhny Novgorod 603950, Russia
6Centro de Investigación en Computación, Instituto Politécnico Nacional (CIC-IPN), Av. Juan de Dios Bátiz, Esq. Miguel Othón de Mendizábal S/N, Gustavo A. Madero, 07738 Mexico City, Mexico
7Central Clinical Hospital of RAS, Litovskiy Blvd. 1A, Moscow 117593, Russia

Correspondence should be addressed to Ildar Batyrshin; moc.liamg@1rytab

Received 15 April 2017; Revised 15 June 2017; Accepted 2 July 2017; Published 7 August 2017

Academic Editor: Giuseppe Murdaca

Copyright © 2017 Nailya Kubysheva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. F. Chung and I. M. Adcock, “Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction,” European Respiratory Journal, vol. 31, no. 6, pp. 1334–1356, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. J. Barnes, “Immunology of asthma and chronic obstructive pulmonary disease,” Nature Reviews Immunology, vol. 8, no. 3, pp. 183–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Rovina, A. Koutsoukou, and N. G. Koulouris, “Inflammation and immune response in COPD: where do we stand?” Mediators of Inflammation, vol. 2013, Article ID 413735, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. P. J. Barnes, B. Chowdhury, S. A. Kharitonov et al., “Pulmonary biomarkers in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 174, pp. 6–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. V. V. Novikov, I. V. Evsegneeva, A. V. Karaulov, and A. J. Baryshnikov, “Soluble forms of membrane antigens of immune system cells in social infections,” Russian Journal Biotherapy, vol. 4, no. 2, pp. 100–105, 2005. View at Google Scholar
  6. R. Blasczyk, U. Westhoff, and H. Grosse-Wilde, “Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations,” The Lancet, vol. 341, no. 8848, pp. 789-790, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. L. M. Dobbe, N. J. Stam, J. J. Neefjes, and M. J. Giphart, “Biochemical complexity of serum HLA class I molecules,” Immunogenetics, vol. 27, no. 3, pp. 203–210, 1988. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Zavazava, “Soluble HLA class I molecules: biological significance and clinical implications,” Molecular Medicine Today, vol. 4, no. 3, pp. 116–121, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Meager, C. Bird, and A. Mire-Sluis, “Assays for measuring soluble cellular adhesion molecules and soluble cytokine receptors,” Journal of Immunological Methods, vol. 191, no. 2, pp. 97–112, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. L. A. Rubin and D. L. Nelson, “The soluble interleukin-2 receptor: biology, function, and clinical application,” Annals of Internal Medicine, vol. 113, no. 8, pp. 619–627, 1990. View at Publisher · View at Google Scholar
  11. S. J. Levine, “Mechanisms of soluble cytokine receptor generation,” The Journal of Immunology, vol. 173, no. 9, pp. 5343–5348, 2004. View at Publisher · View at Google Scholar
  12. P. J. Barnes and M. G. Cosio, “Cells and mediators of chronic obstructive pulmonary disease,” Management of Chronic Obstructive Pulmonary Disease, vol. 38, The Europian Respiratory Monograph, 2006. View at Google Scholar
  13. P. J. Barnes, “The cytokine network in chronic obstructive pulmonary disease,” American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 6, pp. 631–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. L. Heaney and D. W. Golde, “Soluble cytokine receptors,” Blood, vol. 87, no. 3, pp. 847–857, 1996. View at Google Scholar
  15. A. D. Ho, M. Maruyama, A. Maghazachi, J. R. Mason, S. Gluck, and R. E. Corringham, “Soluble CD4, soluble CD8, soluble CD25, lymphopoetic recovery and endogenous cytokines after high dose chemotherapy and blood stem cell transplantation,” Blood, vol. 84, pp. 3550–3557, 1994. View at Google Scholar
  16. J. C. Grimaldi, S. Balasubramanian, N. H. Kabra et al., “CD38-mediated ribosylation of proteins,” Journal of Immunology, vol. 155, pp. 811–817, 1995. View at Google Scholar
  17. C. J. Limas, I. F. Goldenberg, and C. Limas, “Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy correlation with disease severity and cardiac autoantibodies,” Circulation, vol. 91, no. 3, pp. 631–634, 1995. View at Publisher · View at Google Scholar
  18. R. Mallone, S. Ferrua, M. Morra et al., “Characterization of a CD38-like 78-kDa soluble protein released from B cell lines derived from patients with X-linked agammaglobulinemia,” The Journal of Clinical Investigation, vol. 101, pp. 2821–2830, 1998. View at Publisher · View at Google Scholar
  19. D. M. Kemeny, M. Vyas, M. J. Vukmanovic-Stejic, A. Thomas, and L. Noble, “Loh. CD8 (+) T cell subsets and chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 160, pp. 7–33, 1999. View at Publisher · View at Google Scholar
  20. M. Saetta, S. Baraldo, L. Corbino et al., “CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 2, pp. 711–717, 1999. View at Publisher · View at Google Scholar
  21. C. L. Morgan, C. P. Price, S. B. Cohen, J. A. Madrigal, and D. J. Newman, “Soluble CD8 stabilizes the HLA class I molecule by promoting β2M exchange: analysis in real-time,” Human Immunology, vol. 60, no. 5, pp. 442–449, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Takabatake, H. Nakamura, S. Inoue et al., “Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease,” Respiratory Medicine, vol. 94, pp. 1215–1220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Yasuda, K. Gotoh, S. Minatoguchi et al., “An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD,” Respiratory Medicine, vol. 92, pp. 993–999, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Kubysheva, S. Soodaeva, L. Postnikova, V. Novikov, A. Maksimova, and A. Chuchalin, “Associations between indicators of nitrosative stress and levels of soluble HLA-I, CD95 molecules in patients with COPD,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 11, no. 6, pp. 639–644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. E. M. Konstantinidi, A. S. Lappas, A. S. Tzortzi, and P. K. Behrakis, “Exhaled breath condensate: technical and diagnostic aspects,” The Scientific World Journal, vol. 2015, Article ID 435160, 25 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. T. I. Eliseeva, Y. S. Kulpina, S. K. Soodaeva, and N. I. Kubysheva, “Content of the nitrogen oxide metabolites in a condensate of exhaling air in children with a bronchial asthma control different level,” Sovremennye Tehnologii v Medicine, vol. 4, pp. 42–47, 2010. View at Google Scholar
  27. Global Initiative for Chronic Obstructive Lung Disease (GOLD), “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,” Vancouver (WA): Global Initiative for Chronic Obstructive Lung Disease (GOLD), vol. 78, 2011. View at Google Scholar
  28. M. J. Lebedev, M. A. Krizhanova, S. A. Vilkov et al., “Peripheral blood lymphocytes immunophenotype and serum concentration of soluble HLA class I in burns patients,” Burns, vol. 29, no. 2, pp. 123–128, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. V. V. Novikov, M. E. Mamaeva, A. V. Aliasova et al., “The serum level of total and oligomeric fractions of soluble molecules cd38 under malignant tumors of cervix and uterine body,” Klinicheskaia Laboratornaia Diagnostika, vol. 60, no. 5, pp. 32–36, 2015. View at Google Scholar
  30. V. V. Novikov, N. I. Egorova, G. Y. Kurnikov, I. V. Evsegneeva, A. Y. Baryshnikov, and A. V. Karaulov, “Serum levels of soluble HLA and IL-2R molecules in patients with urogenital chlamydia infection,” In Immune-Mediated Diseases Springer New York, vol. 601, pp. 285–289, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. J. Lebedev, N. I. Egorova, M. N. Sholkina, S. A. Vilkov, A. J. Baryshnikov, and V. V. Novikov, “Serum levels of different forms of soluble CD38 antigen in burned patients,” Burns, vol. 30, no. 6, pp. 552–556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Pfister, A. Ogilvie, K. da Silva, A. Grahnert, A. H. Guse, and S. Hauschildt, “NAD degradation and regulation of CD38 expression by human monocytes/macrophages,” European Journal of Biochemistry, vol. 268, pp. 5601–5608, 2001. View at Publisher · View at Google Scholar
  33. F. Malavasi, A. Funaro, S. Roggero, A. Horenstein, L. Calosso, and K. Mehta, “Human CD38: a glycoprotein in search of a function,” Immunology Today, vol. 15, no. 3, pp. 95–97, 1994. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Funaro, A. L. Horenstein, L. Calosso et al., “Identification and characterization of an active soluble form of human CD38 in normal and pathological fluids,” International Immunology, vol. 8, no. 11, pp. 1643–1650, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Alessio, S. Roggero, A. Funaro et al., “CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells,” Journal of Immunology, vol. 145, pp. 878–884, 1990. View at Google Scholar